Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Share price taken down

<< Previous

Bullboard Posts

Next >>

Post by woundedkneeon May 13, 2021 2:09pm

503 Views

Post# 33195835

Share price taken down

By suspicious actions. Very low trading which leads me to believe this is totally manipulated by one or two traders or brokerage houses. I would be concerned if there were hundreds of thousands or millions of shares traded daily, but this is not the case. So if you shorters or MMs want to play this game then go for it..I will buy more as you take it down. As an observation over the past several years I firmaly believe that manipulators just snub their noses at regulators, because they know most times they get away with breaking all the rules. I could say more, but I won't. gl

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?